Advertisement
Screener

HYPERION DEFI, INC. (HYPD) Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value

1.9 / 5 stars · 19/50 Roast Me

HYPERION DEFI, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value

HYPERION DEFI, INC. (HYPD) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value of $8.72 per share for the 3-month period ending 2018-06-30, per its 10-Q filed 2018-08-14.

Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement › Share-Based Payment Arrangement, Disclosure

us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue · last filed 2019-03-27

  • HYPERION DEFI, INC. share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for the quarter ending 2018-06-30 was $8.72.
  • HYPERION DEFI, INC. share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for fiscal 2017 was $1.77, a 52.59% increase from fiscal 2016.
  • HYPERION DEFI, INC. share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for fiscal 2016 was $1.16.
Period endShare-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value 0 monthShare-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value 3 monthShare-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value 6 monthShare-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value 12 month
2018-06-30$8.72
10-Q · filed 2018-08-14
$8.72
10-Q · filed 2018-08-14
2017-12-31$1.77
10-K · filed 2018-04-02
2017-07-07$173900.00
10-K · filed 2019-03-27
2016-12-31$1.16
10-K · filed 2018-04-02

Similar stocks

Stock NameCountryMarket CapPE Ratio
Rein Therapeutics, Inc. (RNTX)United States$0.063B-1.76
XBiotech Inc. (XBIT)United States$0.066B-1.56
Skye Bioscience, Inc. (SKYE)United States$0.061B-0.48
CalciMedica, Inc. (CALC)United States$0.061B-1.42
TALPHERA, INC. (TLPH)United States$0.060B
Connect Biopharma Holdings Ltd (CNTB)$0.069B-2.17
Yarrow Bioscience, Inc. (YARW)United States$0.070B
Boundless Bio, Inc. (BOLD)United States$0.059B-0.88
NOMAD POWER SOLUTIONS, INC. (NMAD)United States$0.058B
PLIANT THERAPEUTICS, INC. (PLRX)United States$0.071B-0.76